Smith & Nephew (LON: SN.) shares were in focus on Friday after HSBC downgraded the stock from Buy to Hold, cutting the price target from 1,160p to 1,070p.
In a research note, HSBC analysts said the company’s recently announced 12-point programme under its current chief executive “comes across more convincingly than previous plans,” highlighting that it includes “specific KPIs that directly address the pain points.”
Analysts suggested that this strategy is more likely to produce gains than previous plans aimed at revitalising the business.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
Despite acknowledging the potential for improvement, HSBC flagged ongoing concerns.
While they noted that Smith & Nephew “trades at a deep discount to peers” and could benefit from the “increasing importance of ASC with a smaller robotic product vs peers,” they cautioned that persistent issues may remain challenging.
The analysts stated: “Although we still believe there is plenty of upside that can be achieved via a successful turnaround of the business, the underperformance, especially in the US knees and hips business, might be difficult to turn around after several years of sequential underperformance.”
Smith & Nephew shares are up around 1.5% so far this year. However, in the last six months, it has dipped by over 6%.
Searching for the Perfect Broker?
Discover our top-recommended brokers for trading and investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!
- IG Top-tier regulation – Read our Review
- eToro Wide range of instruments available to trade – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
